Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $115

Barclays analyst Christopher Pasquale has initiated coverage on DexCom (NASDAQ: DXCM) with an Overweight rating. The firm has set a price target of $115 for the company's stock.